Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]
News [7014]
Articles [265]
Editorials [8]
Conferences [213]
elearning [41]
PSA as a marker of disease in patients with prostate cancer and bone metastases
Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal
PSA as a marker of disease in patients with prostate cancer and bone metastases ( Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal )
28 Feb 2014
ecancermedicalscience Editor's Choice for January 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014
MET variant as a prognostic marker in clear cell renal cell carcinoma
Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA
MET variant as a prognostic marker in clear cell renal cell carcinoma ( Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA )
31 Jan 2014
Gleason score efficacy predictions in abiraterone acetate therapy with mCRPC
Dr Karim Fizazi - Institut Gustave Roussy, Paris, France
Gleason score efficacy predictions in abiraterone acetate therapy with mCRPC ( Dr Karim Fizazi - Institut Gustave Roussy, Paris, France )
31 Jan 2014
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)
Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin...
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014
Understanding the biology of the disease to guide treatment choices
Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland
Understanding the biology of the disease to guide treatment choices ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland )
10 Jan 2014
Drop in breast cancer mortality in developed countries varies
Dr Donald Berry - MD Anderson Cancer Center, Houston, USA
Drop in breast cancer mortality in developed countries varies ( Dr Donald Berry - MD Anderson Cancer Center, Houston, USA )
19 Dec 2013
Hypoxic metabolism in breast cancer: how to overcome resistance to anti...
Prof Adrian Harris - University of Oxford, Oxford, UK
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy ( Prof Adrian Harris - University of Oxford, Oxford, UK )
19 Dec 2013
Where to next for the elderly with acute myeloid leukaemia?
Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert...
Where to next for the elderly with acute myeloid leukaemia? ( Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands )
19 Dec 2013
Anastrozole cuts breast cancer cases by more than 50% in high risk women
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
18 Dec 2013
Benefit of breast cancer screening more consistent across studies than...
Dr Robert Smith - American Cancer Society, Atlanta, USA
Benefit of breast cancer screening more consistent across studies than previously understood ( Dr Robert Smith - American Cancer Society, Atlanta, USA )
16 Dec 2013
Screening mammography, over diagnosis and over treatment
Dr Gilbert Welch - Dartmouth College, Hanover, USA
Screening mammography, over diagnosis and over treatment ( Dr Gilbert Welch - Dartmouth College, Hanover, USA )
12 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation